Gantry-based pencil beam scanning proton therapy for uveal melanoma: IMPT versus proton arc therapy

被引:0
作者
Qi, Hang [1 ]
Hu, Lei [2 ]
Huang, Sheng [3 ]
Lee, Yen-Po [4 ]
Yu, Francis [1 ]
Chen, Qing [1 ]
Yang, Yunjie [5 ]
Kang, Minglei [1 ]
Zhai, Huifang [1 ]
Vermeulen, Milo [1 ]
Shim, Andy [1 ]
Park, Peter [1 ]
Ding, Xuanfeng [6 ]
Zhou, Jun [7 ]
Abramson, David H. [5 ]
Francis, Jasmine H. [5 ]
Simone, Charles B. [1 ,5 ]
Barker, Christopher A. [1 ,5 ]
Lin, Haibo [1 ,5 ,8 ]
机构
[1] New York Proton Ctr, New York, NY 10035 USA
[2] Inova Schar Canc Inst, Fairfax, VA USA
[3] Tianjin Med Univ Canc Inst & Hosp, Tianjin, Peoples R China
[4] Univ Iowa Hlth Care, Iowa City, IA USA
[5] Mem Sloan Kettering Canc Ctr, New York, NY 10029 USA
[6] William Beaumont Univ Hosp, Corewell Hlth, Royal Oak, MI USA
[7] Emory Univ, Atlanta, GA USA
[8] Albert Einstein Coll Med, Montefiore Med Ctr, Dept Radiat Oncol, Bronx, NY 10471 USA
关键词
Uveal melanoma; Pencil beam scanning; Intensity modulated proton therapy; Proton arc therapy; RADIATION-THERAPY; DOSIMETRIC ACCURACY; DELIVERY-EFFICIENT; SPARC THERAPY; RADIOTHERAPY; IRRADIATION; OUTCOMES; CANCER; ROBUST;
D O I
10.1186/s13014-025-02621-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background This study reports the single-institution clinical experience of multifield pencil beam scanning (PBS) intensity-modulated proton therapy (IMPT) and dosimetric comparison to proton arc for uveal melanoma (UM) in a regular PBS gantry room. Methods Eleven consecutive UM patients were treated with IMPT to 50 Gy in 5 fractions. A customized gaze-fixation device attached to the thermoplastic mask was used to reproduce the globe position for each patient. IMPT plans were robustly optimized with perturbations of 3 mm setup and 3.5% range uncertainties using 3-4 fields without apertures. Each plan was robustly reoptimized (using the same perturbation parameters) using two non-coplanar arc fields in the RayStation treatment planning system. Treatment quality for both plans was evaluated daily using CBCT-generated synthetic CT. Target coverage, conformity, and mean/maximum doses to adjacent organs were assessed. Results Proton arc plans provided comparable plan quality compared to IMPT plans. Similar target coverage was achieved, with an average GTV D95% equal to 101.1% +/- 1.0% and 101.4% +/- 0.4% for IMPT and proton arc plans, respectively. Proton arc improves the conformity index (RTOG) compared to IMPT plans (average 0.96 +/- 0.23 vs. 0.88 +/- 0.18, p = 0.11). Both modalities met all the clinical goals for organs-at-risk (OARs), while proton arc significantly reduced the maximum dose for the retina from, on average, 54.5 +/- 0.7 to 53.2 +/- 0.3 Gy (p < 0.01). Treatment evaluation on synthetic CT showed that the doses received by patients were highly consistent with the planned doses, with a relative target coverage (D95%) difference within 3.5% for IMPT and 3.1% for proton arc, and the D95% of actual delivery exceeding 98.7% and 98.2%, respectively. The doses delivered to OARs did not exceed clinical constraints. Conclusions This is a novel report on proton arc for ocular tumors and gantry-based multifield PBS proton treatment for these tumors. This study demonstrated that both modalities can meet the clinical goals. The IMPT is currently clinically implanted, and 2-field non-coplanar proton arc plans can achieve comparable dosimetric metrics to those of IMPT plans when the deliver technique is matured.
引用
收藏
页数:11
相关论文
共 54 条
[1]  
Aziz S, 2009, CLIN OPHTHALMOL, V3, P49
[2]   Dosimetric accuracy of planning and delivering small proton therapy fields [J].
Bednarz, Bryan ;
Daartz, Juliane ;
Paganetti, Harald .
PHYSICS IN MEDICINE AND BIOLOGY, 2010, 55 (24) :7425-7438
[3]   Proton monoenergetic arc therapy (PMAT) to enhance LETd within the target [J].
Bertolet, A. ;
Carabe, A. .
PHYSICS IN MEDICINE AND BIOLOGY, 2020, 65 (16)
[4]   PROTON BEAM RADIOTHERAPY FOR UVEAL MELANOMAS AT NICE TEACHING HOSPITAL: 16 YEARS' EXPERIENCE [J].
Caujolle, Jean-Pierre ;
Mammar, Hamid ;
Chamorey, Emmanuel ;
Pinon, Fabien ;
Herault, Joel ;
Gastaud, Pierre .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (01) :98-103
[5]   Feasibility study: spot-scanning proton arc therapy (SPArc) for left-sided whole breast radiotherapy [J].
Chang, Sheng ;
Liu, Gang ;
Zhao, Lewei ;
Dilworth, Joshua T. ;
Zheng, Weili ;
Jawad, Saada ;
Yan, Di ;
Chen, Peter ;
Stevens, Craig ;
Kabolizadeh, Peyman ;
Li, Xiaoqiang ;
Ding, Xuanfeng .
RADIATION ONCOLOGY, 2020, 15 (01)
[6]  
Collaborative Ocular Melanoma Grp, 2006, ARCH OPHTHALMOL-CHIC, V124, P1684
[7]  
Damato BE, 2012, DEV OPHTHALMOL, V49, P16, DOI 10.1159/000328251
[8]   Proton beam radiotherapy for uveal melanoma: Results of curie institut-orsay proton therapy center (ICPO) [J].
Dendale, Remi ;
Lumbroso-Le Rouic, Livia ;
Noel, Georges ;
Feuvret, Loic ;
Levy, Christine ;
Delacroix, Sabine ;
Meyer, Anne ;
Nauraye, Catherine ;
Mazal, Alejandro ;
Mammar, Hamid ;
Garcia, Paul ;
D'Hermies, Francois ;
Frau, Eric ;
Plancher, Corine ;
Asselain, Bernard ;
Schlienger, Pierre ;
Mazeron, Jean Jacques ;
Desjardins, Laurence .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (03) :780-787
[9]   A linac-based stereotactic irradiation technique of uveal melanoma [J].
Dieckmann, K ;
Bogner, J ;
Georg, D ;
Zehetmayer, M ;
Kren, G ;
Pötter, R .
RADIOTHERAPY AND ONCOLOGY, 2001, 61 (01) :49-56
[10]   Improving dosimetric outcome for hippocampus and cochlea sparing whole brain radiotherapy using spot-scanning proton arc therapy [J].
Ding, Xuanfeng ;
Zhou, Jun ;
Li, Xiaoqiang ;
Blas, Kevin ;
Liu, Gang ;
Wang, Yinan ;
Qin, An ;
Chinnaiyan, Prakash ;
Yan, Di ;
Stevens, Craig ;
Grills, Inga ;
Kabolizadeh, Peyman .
ACTA ONCOLOGICA, 2019, 58 (04) :483-490